Zimmer Biomet Holdings Deferred Tax Assets increased by 2.4% to $249.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1246.3%, from -$21.80M to $249.90M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets shows a downward trend with a -20.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase can signal future tax efficiency or the utilization of past losses, while a decrease may indicate the realization of those benefits.
These are assets on the balance sheet that represent future tax savings resulting from temporary differences between the...
Common in large, capital-intensive companies; peers with significant R&D spending often have large deferred tax assets from tax credits.
deferred_tax_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $722.80M | $693.90M | $558.50M | $490.10M | $526.20M | $541.30M | $474.80M | $484.60M | $474.90M | $465.40M | $357.60M | $370.40M | -$11.93M | -$11.93M | $352.50M | -$21.80M | -$21.80M | -$21.80M | $244.10M | $249.90M |
| QoQ Change | — | -4.0% | -19.5% | -12.2% | +7.4% | +2.9% | -12.3% | +2.1% | -2.0% | -2.0% | -23.2% | +3.6% | -103.2% | +0.0% | >999% | -106.2% | +0.0% | +0.0% | >999% | +2.4% |
| YoY Change | — | — | — | — | -27.2% | -22.0% | -15.0% | -1.1% | -9.7% | -14.0% | -24.7% | -23.6% | -102.5% | -102.6% | -1.4% | -105.9% | -82.8% | -82.8% | -30.8% | >999% |